(1)
Real-World Treatment Outcomes and Safety Profiles of Tyrosine Kinase Inhibitors in Iraqi Patients With Chronic Myeloid Leukemia. mfm 2025, 36 (8). https://doi.org/10.60110/medforum.360807.